I'm not sure its extrodinary for a "biospec" to be wanting to keep their options open in ability to raise future capital. In fact I believe it would be remiss of a board of an emerging company not to explore all avenues as a continegency. There are so many risks associated with OBJ but I'm sure many shareholders are in for the huge upside if things go right. But in a very general sense they have the following risks that may require future capital...
- Potential clients renege, back away, slow down, change direction, change management etc etc - counterparty risk
- Products need more R&D expenditure, new products to be developed, existing products "tweeked " - Product Risk
- Distribution channels to market need investment, marketing costs, resource costs etc - Channel risk
- Key people need to be hired, new skills required, key people risk mitifated - Resource risk
and then of course there's the working capital requirements
So all sorts of reasons required to make sure all possible options are open to raising capital. This is a company that has no revenue but great IP, its kinda a no s**t sherlock moment that they will need funds to grow... all IMO.
Maddoc
- Forums
- ASX - By Stock
- capital raising
I'm not sure its extrodinary for a "biospec" to be wanting to...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online